Amedeo Smart

Free Medical Literature Service


 

Amedeo

Obstructive Lung Diseases

  Free Subscription

Articles published in
Eur Respir J
    August 2022
  1. LEE S, Prokopenko D, Kelly RS, Lutz S, et al
    Zinc finger protein 33B demonstrates sex-interaction with atopy-related markers in childhood asthma.
    Eur Respir J. 2022 Aug 11. pii: 13993003.00479-2022.
    >> Share

  2. BURGEL PR, Roche N
    Cystic fibrosis transmembrane conductance regulator (CFTR): a missing link between smoking and chronic airway diseases?
    Eur Respir J. 2022;60.
    >> Share

  3. BONDONNO NP, Parmenter BH, Dalgaard F, Murray K, et al
    Flavonoid intakes inversely associate with COPD in smokers.
    Eur Respir J. 2022;60.
    >> Share

  4. SAFERALI A, Qiao D, Kim W, Raraigh K, et al
    C FTR variants are associated with chronic bronchitis in smokers.
    Eur Respir J. 2022;60.
    >> Share

    July 2022
  5. PERRET JL, Dharmage SC, Bui DS
    Early life respiratory infections and pre-adult asthma: could there be an interaction and differential misclassification?
    Eur Respir J. 2022 Jul 26. pii: 13993003.01141-2022.
    >> Share

  6. MCLOUGHLIN RF, Clark VL, Urroz PD, Gibson PG, et al
    Increasing physical activity in severe asthma: a systematic review and meta-analysis.
    Eur Respir J. 2022 Jul 26. pii: 13993003.00546-2022.
    >> Share

  7. VAN MEEL ER, Duijts L
    Reply to: "Early-life respiratory infections and pre-adult asthma: could there be an interaction and differential misclassification?"
    Eur Respir J. 2022 Jul 26. pii: 13993003.01384-2022.
    >> Share

  8. MURPHY VE, Jensen ME, Holliday EG, Giles WB, et al
    Effect of asthma management with exhaled nitric oxide versus usual care on perinatal outcomes.
    Eur Respir J. 2022 Jul 1. pii: 13993003.00298-2022.
    >> Share

  9. REDMOND C, Heaney LG, Chaudhuri R, Jackson DJ, et al
    Benefits of specialist severe asthma management: demographic and geographic disparities.
    Eur Respir J. 2022 Jul 1. pii: 13993003.00660-2022.
    >> Share

  10. HOLMES J, McGarvey LP, Birring SS, Fletcher H, et al
    An observational study to determine the relationship between cough frequency and markers of inflammation in severe asthma.
    Eur Respir J. 2022 Jul 1. pii: 13993003.03205-2021.
    >> Share

  11. SALTER B, Zhao N, Son K, Suray Tan N, et al
    Airway autoantibodies are determinants of asthma severity.
    Eur Respir J. 2022 Jul 1. pii: 13993003.00442-2022.
    >> Share

  12. WURZEL D, Licciardi PV
    Targeted strategies are needed to prevent childhood asthma.
    Eur Respir J. 2022;60.
    >> Share

  13. KAZA N, Lin VY, Stanford D, Hussain SS, et al
    Evaluation of a novel CFTR potentiator in COPD ferrets with acquired CFTR dysfunction.
    Eur Respir J. 2022;60.
    >> Share

  14. WARK PAB
    We need to understand why viral infections lead to acute asthma.
    Eur Respir J. 2022;60.
    >> Share

  15. MATTILA T, Erhola M, Vasankari T, Toppila-Salmi S, et al
    Controlling chronic respiratory diseases in Finland from 1996 to 2018.
    Eur Respir J. 2022;60.
    >> Share

  16. VAN HULST G, Jorssen J, Jacobs N, Henket M, et al
    Reply: Ex vivo SOCS3 gene responsiveness to alarmins in eosinophils of mepolizumab-treated patients is as yet of unknown biological significance.
    Eur Respir J. 2022;60.
    >> Share

  17. COUILLARD S
    The alarmin(g) effect of interleukin-5 blockade on residual eosinophil function is of clinical consequence.
    Eur Respir J. 2022;60.
    >> Share

  18. MCINNIS MC, Ma J, Karur GR, Houbois C, et al
    Chronic lung allograft dysfunction phenotype and prognosis by machine learning CT analysis.
    Eur Respir J. 2022;60.
    >> Share

    June 2022
  19. SHOEMARK A, Griffin H, Wheway G, Hogg C, et al
    Genome sequencing reveals underdiagnosis of primary ciliary dyskinesia in bronchiectasis.
    Eur Respir J. 2022 Jun 21. pii: 13993003.00176-2022.
    >> Share

  20. CHANG AB, Zacharasiewicz A, Goyal V, Boyd J, et al
    Task Force report: European Respiratory Society statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials.
    Eur Respir J. 2022 Jun 21. pii: 13993003.00300-2022.
    >> Share


  21. "International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma." Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, et al. Eur Respir J 2014; 43: 343-373.
    Eur Respir J. 2022;59.
    >> Share

  22. CAZZOLA M, Martinez-Garcia MA, Matera MG
    Bronchodilators in bronchiectasis: there is light but it is still too dim.
    Eur Respir J. 2022;59.
    >> Share

  23. CHANG AB, Boyd J, Bush A, Hill AT, et al
    International consensus statement on quality standards for managing children/adolescents with bronchiectasis from the ERS CRC Child-BEAR-Net.
    Eur Respir J. 2022;59.
    >> Share

  24. YUGE M, Hori S, Ushida K, Momosaki R, et al
    Karaoke as a feasible alternative therapy to pulmonary rehabilitation for COPD.
    Eur Respir J. 2022;59.
    >> Share

  25. LOKKE A, Kaasgaard M, Andreasson KH, Rasmussen DB, et al
    Reply: The effectiveness of singing versus exercise training.
    Eur Respir J. 2022;59.
    >> Share

  26. VAES AW, Spruit MA, Franssen FME, van 't Hul AJ, et al
    The efficacy of singing versus exercise training: do the data really support the authors' conclusions?
    Eur Respir J. 2022;59.
    >> Share

  27. BATEMAN ED, Price DB, Wang HC, Schonffeldt P, et al
    Reply to: Cause or consequence?
    Eur Respir J. 2022;59.
    >> Share

  28. VOLPE FM
    Cause or consequence?
    Eur Respir J. 2022;59.
    >> Share

  29. CHALMERS JD, Aksamit T, Aliberti S, Dhar R, et al
    World Bronchiectasis Day 2022.
    Eur Respir J. 2022;59.
    >> Share

    May 2022
  30. WOEHLK C, Von Bulow A, Ghanizada M, Baastrup Sondergaard M, et al
    Allergen immunotherapy effectively reduces the risk of exacerbations and lower respiratory tract infections in both seasonal and perennial allergic asthma: a nationwide epidemiological study.
    Eur Respir J. 2022 May 26. pii: 13993003.00446-2022.
    >> Share

  31. SUN Y, Zhang M, Ou Z, Meng Y, et al
    Indoor microbiome, microbial and plant metabolites, chemical compounds and asthma symptoms in junior high school students: a multicentre association study in Malaysia.
    Eur Respir J. 2022 May 26. pii: 13993003.00260-2022.
    >> Share

  32. HUMBERT M, Bourdin A, Taille C, Kamar D, et al
    Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of pediatric and adult asthmatics.
    Eur Respir J. 2022 May 26. pii: 13993003.03130-2021.
    >> Share

  33. HABENER A, Grychtol R, Gaedcke S, DeLuca D, et al
    IgA(+) memory B cells are significantly increased in patients with asthma and small airways dysfunction.
    Eur Respir J. 2022 May 20. pii: 13993003.02130-2021.
    >> Share

  34. KROES JA, Zielhuis SW, De Jong K, Hashimoto S, et al
    Cumulative Corticosteroid Sparing Effect of Anti-Interleukin-5/5Ra In Eosinophilic Asthma.
    Eur Respir J. 2022 May 20. pii: 13993003.02983-2021.
    >> Share

  35. AZZO L, Ali YS, Vaqar S, Dauriat G, et al
    Severe pulmonary hypertension associated with chronic obstructive pulmonary disease Long-term results of a prospective French multicenter cohort.
    Eur Respir J. 2022 May 20. pii: 13993003.02897-2021.
    >> Share

  36. KOEHLER P, von Stillfried S, Garcia Borrega J, Fuchs F, et al
    Aspergillus tracheobronchitis in COVID-19 patients with acute respiratory distress syndrome: a cohort study.
    Eur Respir J. 2022;59.
    >> Share

  37. MATHIOUDAKIS AG, Abroug F, Agusti A, Ananth S, et al
    ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations.
    Eur Respir J. 2022;59.
    >> Share

  38. GAIETTO K, Han YY, Forno E, Bacharier LB, et al
    Violence-related distress and lung function in two longitudinal studies of youth.
    Eur Respir J. 2022;59.
    >> Share

  39. LATIMER LE, Constantin-Teodosiu D, Popat B, Constantin D, et al
    Whole-body and muscle responses to aerobic exercise training and withdrawal in ageing and COPD.
    Eur Respir J. 2022;59.
    >> Share

  40. SORIANO JB, Hopkinson NS
    Sing out for COPD!
    Eur Respir J. 2022;59.
    >> Share

  41. VESTBO J, Waterer G, Leather D, Crim C, et al
    Mortality after admission with pneumonia is higher than after admission with an exacerbation of COPD.
    Eur Respir J. 2022;59.
    >> Share

  42. YUN JH, Lee S, Srinivasa P, Morrow J, et al
    An interferon-inducible signature of airway disease from blood gene expression profiling.
    Eur Respir J. 2022;59.
    >> Share

  43. KAASGAARD M, Rasmussen DB, Andreasson KH, Hilberg O, et al
    Use of Singing for Lung Health as an alternative training modality within pulmonary rehabilitation for COPD: a randomised controlled trial.
    Eur Respir J. 2022;59.
    >> Share

  44. FAIZ A, van den Berge M
    Quality over quantity: the importance of collecting relevant samples to understand complex diseases.
    Eur Respir J. 2022;59.
    >> Share

  45. HIGHAM A, Beech A, Jackson N, Lea S, et al
    Sputum cell counts in COPD patients who use electronic cigarettes.
    Eur Respir J. 2022;59.
    >> Share

  46. XU F, Vasilescu DM, Kinose D, Tanabe N, et al
    The molecular and cellular mechanisms associated with the destruction of terminal bronchioles in COPD.
    Eur Respir J. 2022;59.
    >> Share

    April 2022
  47. RABE KF, Pavord ID, Castro M, Wechsler ME, et al
    Dupilumab efficacy and safety in patients with asthma and blood eosinophils >/=500 cells.microL(-1).
    Eur Respir J. 2022 Apr 29. pii: 13993003.02577-2021.
    >> Share

  48. VAN MEEL ER, Mensink-Bout SM, den Dekker HT, Ahluwalia TS, et al
    Early-life respiratory tract infections and the risk of school-age lower lung function and asthma: a meta-analysis of 150 000 European children.
    Eur Respir J. 2022 Apr 29. pii: 13993003.02395-2021.
    >> Share

  49. MENSINK-BOUT SM, van Meel ER, de Jongste JC, Annesi-Maesano I, et al
    Maternal diet in pregnancy and child's respiratory outcomes: an individual participant data meta-analysis of 18 000 children.
    Eur Respir J. 2022;59.
    >> Share

  50. SKRONSKA-WASEK W, Durlanik S, Le HQ, Schroeder V, et al
    The antimicrobial peptide S100A8/A9 produced by airway epithelium functions as a potent and direct regulator of macrophage phenotype and function.
    Eur Respir J. 2022;59.
    >> Share

  51. SINGH D, Beier J, Astbury C, Belvisi MG, et al
    The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD.
    Eur Respir J. 2022;59.
    >> Share

    March 2022
  52. THOMAS D, McDonald VM, Pavord ID, Gibson PG, et al
    Asthma remission- what is it and how can it be achieved?
    Eur Respir J. 2022 Mar 31. pii: 13993003.02583-2021.
    >> Share

  53. SCHILDKNECHT K, Winthrop KL, Prevots DR, Blakney R, et al
    Nontuberculous mycobacterial pulmonary disease incidence among elderly patients with bronchiectasis.
    Eur Respir J. 2022 Mar 31. pii: 13993003.00018-2022.
    >> Share

  54. HUYNH C, Whitmore GA, Vandemheen KL, FitzGerald JM, et al
    Derivation and Validation of the UCAP-Q Case-finding Questionnaire to Detect Undiagnosed Asthma and COPD.
    Eur Respir J. 2022 Mar 24. pii: 13993003.03243-2021.
    >> Share

  55. HAN YY, Yan Q, Chen W, Celedon JC, et al
    Child maltreatment, anxiety and depression, and asthma among British adults in the UK Biobank.
    Eur Respir J. 2022 Mar 17. pii: 13993003.03160-2021.
    >> Share

  56. BAL C, Idzko M, Skrgat S, Koch A, et al
    FeNO is associated with disease burden in the German Asthma Net severe asthma cohort.
    Eur Respir J. 2022 Mar 10. pii: 13993003.01233-2021.
    >> Share

  57. KLEIN DK, Silberbrandt A, Frossing L, Hvidtfeldt M, et al
    Impact of former smoking exposure on airway eosinophilic activation and autoimmunity in patients with severe asthma.
    Eur Respir J. 2022 Mar 2. pii: 13993003.02446-2021.
    >> Share

  58. VONK JM, Roukema J
    Air pollution susceptibility in children with asthma and obesity: tidal volume as key player?
    Eur Respir J. 2022;59.
    >> Share

  59. POLVERINO F
    Adaptive immune responses and protein homeostasis in COPD: the immunoproteasome.
    Eur Respir J. 2022;59.
    >> Share

  60. THAMRIN C, Robinson PD, Farah CS, King GG, et al
    Technical standards for respiratory oscillometry and bronchodilator response cut-offs.
    Eur Respir J. 2022;59.
    >> Share

  61. KAMMERL IE, Hardy S, Flexeder C, Urmann A, et al
    Activation of immune cell proteasomes in peripheral blood of smokers and COPD patients: implications for therapy.
    Eur Respir J. 2022;59.
    >> Share

  62. DAGHER R, Kumar V, Copenhaver AM, Gallagher S, et al
    Novel mechanisms of action contributing to benralizumab's potent anti-eosinophilic activity.
    Eur Respir J. 2022;59.
    >> Share

    February 2022
  63. MAISON N, Omony J, Illi S, Thiele D, et al
    T-high asthma phenotypes across life span.
    Eur Respir J. 2022 Feb 24. pii: 13993003.02288-2021.
    >> Share

  64. ALI GB, Lowe AJ, Perret JL, Walters EH, et al
    Impact of lifetime body mass index trajectories on the incidence and persistence of adult asthma.
    Eur Respir J. 2022 Feb 24. pii: 13993003.02286-2021.
    >> Share

  65. MORTIMER K, Reddel HK, Pitrez PM, Bateman ED, et al
    Asthma management in low- and middle-income countries: case for change.
    Eur Respir J. 2022 Feb 24. pii: 13993003.03179-2021.
    >> Share

  66. MORTIMER K, Lesosky M, Garcia-Marcos L, Innes Asher M, et al
    The burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study.
    Eur Respir J. 2022 Feb 24. pii: 13993003.02865-2021.
    >> Share

  67. MOSLEMI A, Kontogianni K, Brock J, Wood S, et al
    Differentiating COPD and Asthma using Quantitative CT Imaging and Machine Learning.
    Eur Respir J. 2022 Feb 24. pii: 13993003.03078-2021.
    >> Share

  68. LOUIS R, Satia I, Ojanguren I, Schleich F, et al
    European Respiratory Society Guidelines for the Diagnosis of Asthma in Adults.
    Eur Respir J. 2022 Feb 15. pii: 13993003.01585-2021.
    >> Share

  69. SKOV IR, Madsen H, Henriksen DP, Andersen JH, et al
    Low dose oral corticosteroids in asthma associates with increased morbidity and mortality.
    Eur Respir J. 2022 Feb 10. pii: 13993003.03054-2021.
    >> Share

  70. TAYTARD J, Koskas M, Beydon N
    Spirometry forced expiratory time is driven by airflow limitation in asthmatic children.
    Eur Respir J. 2022 Feb 10. pii: 13993003.02620-2021.
    >> Share

  71. GARCIA-MARCOS L, Innes Asher M, Pearce N, Ellwood E, et al
    The burden of asthma, hay fever and eczema in children in 25 countries: GAN Phase I study.
    Eur Respir J. 2022 Feb 10. pii: 13993003.02866-2021.
    >> Share

  72. MARCON A, Locatelli F, Accordini S
    The coexistence of asthma and COPD: some considerations about prevalence and lung function decline.
    Eur Respir J. 2022 Feb 3. pii: 13993003.00096-2022.
    >> Share

  73. KEARNS N, Bruce P, Williams M, Doppen M, et al
    Repeated dose budesonide/formoterol compared to salbutamol in adult asthma: A randomised cross-over trial.
    Eur Respir J. 2022 Feb 3. pii: 13993003.02309-2021.
    >> Share

  74. SEYS SF, Long MB
    The quest for biomarkers in asthma: challenging the T2 versus non-T2 paradigm.
    Eur Respir J. 2022;59.
    >> Share

  75. ZHANG PD, Zhang XR, Zhang A, Li ZH, et al
    Associations of genetic risk and smoking with incident COPD.
    Eur Respir J. 2022;59.
    >> Share

  76. FRANCIOSI AN, Fraughen D, Carroll TP, McElvaney NG, et al
    Alpha-1 antitrypsin deficiency: clarifying the role of the putative protective threshold.
    Eur Respir J. 2022;59.
    >> Share

    January 2022
  77. PARASKAKIS E, Sarikloglou E, Fouzas S, Steiropoulos P, et al
    Improved prediction of asthma exacerbations by measuring distal airway inflammation.
    Eur Respir J. 2022 Jan 27. pii: 13993003.01684-2021.
    >> Share

  78. RICCARDI D, Ward JP, Yarova PL, Janssen LJ, et al
    Topical therapy with negative allosteric modulators of the calcium-sensing receptor (calcilytics) for the management of asthma: the beginning of a new era?
    Eur Respir J. 2022 Jan 20. pii: 13993003.02103-2021.
    >> Share

  79. AL-SHAIKHLY T, Murphy RC, Parker A, Lai Y, et al
    Location of eosinophils in the airway wall is critical for specific features of airway hyperresponsiveness and T2 inflammation in asthma.
    Eur Respir J. 2022 Jan 13. pii: 13993003.01865-2021.
    >> Share

  80. PEROTIN JM, Wheway G, Tariq K, Azim A, et al
    Vulnerability to acid reflux of the airway epithelium in severe asthma.
    Eur Respir J. 2022 Jan 7. pii: 13993003.01634-2021.
    >> Share

  81. RAMIS J, Middlewick R, Pappalardo F, Cairns JT, et al
    Lysyl oxidase-like 2 is increased in asthma and contributes to asthmatic airway remodelling.
    Eur Respir J. 2022 Jan 7. pii: 13993003.04361-2020.
    >> Share

  82. COLAK Y, Lange P
    Interpreting blood eosinophil counts in health and obstructive lung disease.
    Eur Respir J. 2022;59.
    >> Share

  83. BENSON VS, Hartl S, Barnes N, Galwey N, et al
    Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis.
    Eur Respir J. 2022;59.
    >> Share

    December 2021
  84. RAITA Y, Perez-Losada M, Freishtat RJ, Hahn A, et al
    Nasopharyngeal metatranscriptome profiles of infants with bronchiolitis and risk of childhood asthma: a multicentre prospective study.
    Eur Respir J. 2021 Dec 16. pii: 13993003.02293-2021.
    >> Share

  85. PORSBJERG C, Nieto-Fontarigo JJ, Cerps S, Ramu S, et al
    Phenotype and severity of asthma determines bronchial epithelial immune responses to a viral mimic.
    Eur Respir J. 2021 Dec 16. pii: 13993003.02333-2021.
    >> Share

  86. AGARWAL R, Muthu V
    Prednisolone plus itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma.
    Eur Respir J. 2021 Dec 9. pii: 13993003.02989-2021.
    >> Share

  87. HAVETTE A, Regard L, Roche N, Burgel PR, et al
    Prednisolone plus itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma: is the benefit worth the risk?
    Eur Respir J. 2021 Dec 9. pii: 13993003.02924-2021.
    >> Share

  88. KRUIZINGA MD, Essers E, Stuurman FE, Yavuz Y, et al
    Clinical validation of digital biomarkers for pediatric patients with asthma and cystic fibrosis - Potential for clinical trials and clinical care.
    Eur Respir J. 2021 Dec 9. pii: 13993003.00208-2021.
    >> Share

  89. GURDENIZ G, Ernst M, Rago D, Kim M, et al
    Neonatal metabolome of cesarean section and risk of childhood asthma.
    Eur Respir J. 2021 Dec 9. pii: 13993003.02406-2021.
    >> Share

  90. RYAN D, Sabroe I
    Identifying and addressing health inequalities in asthma care.
    Eur Respir J. 2021;58.
    >> Share

  91. PAPAIOANNOU AI, Photiades A, Gaga M
    Using placebo-controlled trials to define predictors of future exacerbations in severe asthma patients.
    Eur Respir J. 2021;58.
    >> Share

  92. CHALMERS JD, Keir HR
    Less is more? Antibiotic treatment duration for exacerbations of bronchiectasis.
    Eur Respir J. 2021;58.
    >> Share

  93. KURODA N, Shiroshita A, Tsujimoto Y
    Room for methodological improvement in gait speed study for COPD patients.
    Eur Respir J. 2021;58.
    >> Share

  94. WALSH JA, Barker RE, Kon SSC, Jones SE, et al
    Reply to: Room for methodological improvement in gait speed study for COPD patients.
    Eur Respir J. 2021;58.
    >> Share

  95. LIU S, Lim YH, Pedersen M, Jorgensen JT, et al
    Long-term air pollution and road traffic noise exposure and COPD: the Danish Nurse Cohort.
    Eur Respir J. 2021;58.
    >> Share

  96. HERNANDEZ CORDERO AI, Yang CX, Milne S, Li X, et al
    Epigenetic blood biomarkers of ageing and mortality in COPD.
    Eur Respir J. 2021;58.
    >> Share

  97. BEDI P, Cartlidge MK, Zhang Y, Turnbull K, et al
    Feasibility of shortening intravenous antibiotic therapy for bronchiectasis based on bacterial load: a proof-of-concept randomised controlled trial.
    Eur Respir J. 2021;58.
    >> Share

  98. PARK S, Lee S, Kim Y, Cho S, et al
    Kidney function and obstructive lung disease: a bidirectional Mendelian randomisation study.
    Eur Respir J. 2021;58.
    >> Share

    November 2021
  99. ABDEL-AZIZ MI, Vijverberg SJH, Neerincx AH, Brinkman P, et al
    A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes.
    Eur Respir J. 2021 Nov 25. pii: 13993003.02603-2021.
    >> Share

  100. REINKE SN, Naz S, Chaleckis R, Gallart-Ayala H, et al
    Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study.
    Eur Respir J. 2021 Nov 25. pii: 13993003.01733-2021.
    >> Share

  101. JAYARAM L, Vandal AC, Chang C, Lewis C, et al
    Tiotropium treatment for bronchiectasis: a randomised, placebo-controlled, crossover trial.
    Eur Respir J. 2021 Nov 18. pii: 13993003.02184-2021.
    >> Share

  102. MIKUS MS, Kolmert J, Andersson LI, Ostling J, et al
    Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation.
    Eur Respir J. 2021 Nov 4. pii: 13993003.00142-2021.
    >> Share

  103. STRIDSMAN C, Vanfleteren LEGW, Konradsen JR, Axelsson Fisk S, et al
    Predictors of severe COVID-19 in a registry-based Swedish cohort of patients with COPD.
    Eur Respir J. 2021;58.
    >> Share

  104. OLIVER BG
    Food for thought: why is there more airway smooth muscle in asthma?
    Eur Respir J. 2021;58.
    >> Share

  105. MANNINO DM
    Asthma, COPD and their overlap: coexistence or something more?
    Eur Respir J. 2021;58.
    >> Share

  106. WALSH JA, Barker RE, Kon SSC, Jones SE, et al
    Gait speed and adverse outcomes following hospitalised exacerbation of COPD.
    Eur Respir J. 2021;58.
    >> Share

  107. FINNEGAN SL, Harrison OK, Harmer CJ, Herigstad M, et al
    Breathlessness in COPD: linking symptom clusters with brain activity.
    Eur Respir J. 2021;58.
    >> Share

    October 2021
  108. PIJNENBURG MW, Frey U, De Jongste JC, Saglani S, et al
    Childhood asthma- pathogenesis and phenotypes.
    Eur Respir J. 2021 Oct 28. pii: 13993003.00731-2021.
    >> Share

  109. ELSEY L, Pantin T, Holmes LJ, Tavernier G, et al
    Outcomes over the first two years of treatment with mepolizumab in severe asthma.
    Eur Respir J. 2021 Oct 28. pii: 13993003.01313-2021.
    >> Share

  110. SIBILA O, Laserna E, Shoemark A, Perea L, et al
    Heterogeneity of treatment response in bronchiectasis clinical trials.
    Eur Respir J. 2021 Oct 21. pii: 13993003.00777-2021.
    >> Share

  111. REDDEL HK, Bacharier LB, Bateman ED, Brightling CE, et al
    Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes.
    Eur Respir J. 2021 Oct 19. pii: 13993003.02730-2021.
    >> Share

  112. CHAN R, Misirovs R, Lipworth B
    Repeatability of impulse oscillometry in patients with severe asthma.
    Eur Respir J. 2021 Oct 8. pii: 13993003.01679-2021.
    >> Share

  113. SUN Y, Xia PF, Xie J, Mustieles V, et al
    Association of blood trihalomethane concentrations with asthma in U.S. adolescents: nationally representative cross-sectional study.
    Eur Respir J. 2021 Oct 8. pii: 13993003.01440-2021.
    >> Share

  114. PORSBJERG C, Maitland-van der Zee AH, Brusselle G, Canonica GW, et al
    3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD.
    Eur Respir J. 2021;58.
    >> Share

  115. CHANG AB, Boyd J, Bush A, Grimwood K, et al
    Children's Bronchiectasis Education Advocacy and Research Network (Child-BEAR-Net): an ERS Clinical Research Collaboration on improving outcomes of children and adolescents with bronchiectasis.
    Eur Respir J. 2021;58.
    >> Share

  116. KEIR HR, Chalmers JD
    IL-6 trans-signalling: how Haemophilus surfs the NET to amplify inflammation in COPD.
    Eur Respir J. 2021;58.
    >> Share

  117. PETOUSI N, Wooden A, Russell REK
    A new piece in the puzzle: the eosinophil and the development of COPD.
    Eur Respir J. 2021;58.
    >> Share

  118. WINSLOW S, Odqvist L, Diver S, Riise R, et al
    Multi-omics links IL-6 trans-signalling with neutrophil extracellular trap formation and Haemophilus infection in COPD.
    Eur Respir J. 2021;58.
    >> Share

  119. PHILIP J, Collins A, Smallwood N, Chang YK, et al
    Referral criteria to palliative care for patients with respiratory disease: a systematic review.
    Eur Respir J. 2021;58.
    >> Share

  120. PARK HY, Chang Y, Kang D, Hong YS, et al
    Blood eosinophil counts and the development of obstructive lung disease: the Kangbuk Samsung Health Study.
    Eur Respir J. 2021;58.
    >> Share

  121. HIRAI K, Tanaka A, Sato H, Sato Y, et al
    Effect of surgical mask on exercise capacity in COPD: a randomised crossover trial.
    Eur Respir J. 2021;58.
    >> Share

    September 2021
  122. MIURA S, Iwamoto H, Omori K, Yamaguchi K, et al
    Accelerated decline in lung function in adults with a history of remitted childhood asthma.
    Eur Respir J. 2021 Sep 29. pii: 13993003.00305-2021.
    >> Share

  123. BATEMAN ED, Price DB, Wang HC, Khattab A, et al
    Short-acting beta2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study.
    Eur Respir J. 2021 Sep 24. pii: 13993003.01402-2021.
    >> Share

  124. BUSBY J, Matthews JG, Chaudhuri R, Pavord ID, et al
    Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma.
    Eur Respir J. 2021 Sep 24. pii: 13993003.00768-2021.
    >> Share

  125. PANAGOU P, Tzilas V, Bouros D
    "Dynamic (C dyn) lung compliance in non-smokers with asthma and fixed, non-reversible airflow obstruction" ERJ 2021 58: 2004400.
    Eur Respir J. 2021 Sep 24. pii: 13993003.02361-2021.
    >> Share

  126. AGARWAL R, Muthu V, Sehgal IS, Dhooria S, et al
    A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma.
    Eur Respir J. 2021 Sep 9. pii: 13993003.01787-2021.
    >> Share

  127. VAN HULST G, Jorssen J, Jacobs N, Henket M, et al
    Anti-IL-5 mepolizumab minimally influences residual blood eosinophils in severe asthma.
    Eur Respir J. 2021 Sep 2. pii: 13993003.00935-2021.
    >> Share

  128. GREDIC M, Wu CY, Hadzic S, Pak O, et al
    Myeloid cell-specific deletion of inducible nitric oxide synthase protects against smoke-induced pulmonary hypertension in mice.
    Eur Respir J. 2021 Sep 2. pii: 13993003.01153-2021.
    >> Share

  129. GARCIA-LARSEN V
    Omega-3 polyunsaturated fatty acids and FADS genotype: is personalised prevention of asthma on the horizon?
    Eur Respir J. 2021;58.
    >> Share

  130. RUFFLES T, Lipworth B, Mukhopadhyay S
    Considerations of a real life pragmatic clinical trial in adolescent asthma.
    Eur Respir J. 2021;58.
    >> Share

  131. VAN BOVEN JFM, Dierick BJH, Usmani OS
    When biology meets behaviour: can medication adherence mask the contribution of pharmacogenetic effects in asthma?
    Eur Respir J. 2021;58.
    >> Share

  132. LOUIS R, Louis G, Bonhomme O
    NOVELTY: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice.
    Eur Respir J. 2021;58.
    >> Share

  133. BAFADHEL M, Barnes N, Bourke SC, Compton C, et al
    A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial.
    Eur Respir J. 2021;58.
    >> Share

    August 2021
  134. ROFFEL MP, Boudewijn IM, van Nijnatten JLL, Faiz A, et al
    Identification of asthma associated microRNAs in bronchial biopsies.
    Eur Respir J. 2021 Aug 26. pii: 13993003.01294-2021.
    >> Share

  135. KEIR HR, Shoemark A, Huang JTJ, Chalmers JD, et al
    SPLUNC1 is a novel marker of disease severity and airway infection in bronchiectasis.
    Eur Respir J. 2021 Aug 19. pii: 13993003.01840-2021.
    >> Share

  136. SUNJAYA AP, Allida SM, Di Tanna GL, Jenkins CR, et al
    Asthma and Coronavirus Disease 2019 Risk: a systematic review and meta-analysis.
    Eur Respir J. 2021 Aug 12. pii: 13993003.01209-2021.
    >> Share

  137. WU M, Xie J, Wang Y, Tian Y, et al
    Greenness and eosinophilic asthma: Findings from the UK Biobank.
    Eur Respir J. 2021 Aug 12. pii: 13993003.01597-2021.
    >> Share

  138. AFSHAR-MOHAJER N, Wu TD, Shade R, Brigham E, et al
    Obesity, tidal volume, and pulmonary deposition of fine particulate matter in children with asthma.
    Eur Respir J. 2021 Aug 12. pii: 13993003.00209-2021.
    >> Share

  139. IZQUIERDO JL, Soriano JB
    Biologics may have a beneficial effect in asthma patients with COVID-19.
    Eur Respir J. 2021;58.
    >> Share

  140. ZEDER K, Avian A, Bachmaier G, Douschan P, et al
    Elevated pulmonary vascular resistance predicts mortality in COPD patients.
    Eur Respir J. 2021;58.
    >> Share

  141. HARTLEY T, Lane ND, Steer J, Elliott MW, et al
    The Noninvasive Ventilation Outcomes (NIVO) score: prediction of in-hospital mortality in exacerbations of COPD requiring assisted ventilation.
    Eur Respir J. 2021;58.
    >> Share

  142. BROXTERMAN RM, Wagner PD, Richardson RS
    Exercise training in COPD: muscle O2 transport plasticity.
    Eur Respir J. 2021;58.
    >> Share

    July 2021
  143. WECKMANN M, Bahmer T, Bulow Sand JM, Rank Ronnow S, et al
    COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy.
    Eur Respir J. 2021 Jul 29. pii: 13993003.03969-2020.
    >> Share

  144. BUSSE WW, Paggiaro P, Munoz X, Casale TB, et al
    Impact of baseline patient characteristics on dupilumab efficacy in type 2 asthma.
    Eur Respir J. 2021 Jul 29. pii: 13993003.04605-2020.
    >> Share

  145. HAN YY, Forno E, Bacharier LB, Phipatanakul W, et al
    Vitamin D supplementation, lung function, and asthma control in children with asthma and low vitamin D levels.
    Eur Respir J. 2021 Jul 29. pii: 13993003.00989-2021.
    >> Share

  146. CORREN J, Katelaris CH, Castro M, Maspero JF, et al
    Effect of exacerbation history on clinical response to dupilumab in moderate-severe uncontrolled asthma.
    Eur Respir J. 2021 Jul 15. pii: 13993003.04498-2020.
    >> Share

  147. WARK PA, Pathinayake PS, Eapen MS, Sohal SS, et al
    Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights.
    Eur Respir J. 2021 Jul 8. pii: 13993003.00920-2021.
    >> Share

  148. SUNDE RB, Thorsen J, Pedersen CT, Stokholm J, et al
    Prenatal tobacco exposure and risk of asthma and allergy outcomes in childhood.
    Eur Respir J. 2021 Jul 8. pii: 13993003.00453-2021.
    >> Share

  149. RAMAKRISHNAN S, Couillard S
    Antibiotics for asthma attacks: masking uncertainty.
    Eur Respir J. 2021;58.
    >> Share

  150. MILNE S, Li X, Yang CX, Leitao Filho FS, et al
    Inhaled corticosteroids downregulate SARS-CoV-2-related genes in COPD: results from a randomised controlled trial.
    Eur Respir J. 2021;58.
    >> Share

  151. YOUNG RP, Scott RJ
    Statins as adjunct therapy in COPD: is it time to target innate immunity and cardiovascular risk?
    Eur Respir J. 2021;58.
    >> Share

  152. LEVY L, Huszti E, Berra G, Renaud-Picard B, et al
    The accuracy of forced vital capacity for diagnosing restrictive allograft syndrome and mixed phenotype of chronic lung allograft dysfunction.
    Eur Respir J. 2021;58.
    >> Share

  153. RUTTING S, Badal T, Wallis R, Schoeffel RE, et al
    Long-term variability of oscillatory impedance in stable obstructive airways disease.
    Eur Respir J. 2021;58.
    >> Share

  154. SCHENK P, Spiel AO, Huttinger F, Gmeiner M, et al
    Can simvastatin reduce COPD exacerbations? A randomised double-blind controlled study.
    Eur Respir J. 2021;58.
    >> Share

  155. EVANGELOPOULOS D, Chatzidiakou L, Walton H, Katsouyanni K, et al
    Personal exposure to air pollution and respiratory health of COPD patients in London.
    Eur Respir J. 2021;58.
    >> Share

    June 2021
  156. MOORE WC, Kornmann O, Humbert M, Poirier C, et al
    Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study).
    Eur Respir J. 2021 Jun 25. pii: 13993003.00396-2021.
    >> Share

  157. KRAFT M, Brusselle G, Mark FitzGerald J, Pavord ID, et al
    Patient characteristics, biomarkers, and exacerbation risk in severe, uncontrolled asthma.
    Eur Respir J. 2021 Jun 10. pii: 13993003.00413-2021.
    >> Share

  158. THURSTON GD, Lee A
    Evidence of air pollution exposure and new asthma onset: further justification for cleaner air.
    Eur Respir J. 2021;57.
    >> Share

  159. WEATHERALL M
    Improving adherence to asthma medications: same-old, same-old?
    Eur Respir J. 2021;57.
    >> Share

  160. LIU S, Jorgensen JT, Ljungman P, Pershagen G, et al
    Long-term exposure to low-level air pollution and incidence of asthma: the ELAPSE project.
    Eur Respir J. 2021;57.
    >> Share

  161. KUNISAKI KM, Sin DD
    Methylxanthines in COPD: yes to caffeine, no to theophylline.
    Eur Respir J. 2021;57.
    >> Share

  162. HULL JH, Jackson AR, Ranson C, Brown F, et al
    The benefits of a systematic assessment of respiratory health in illness-susceptible athletes.
    Eur Respir J. 2021;57.
    >> Share

  163. JENKINS CR, Wen FQ, Martin A, Barnes PJ, et al
    The effect of low-dose corticosteroids and theophylline on the risk of acute exacerbations of COPD: the TASCS randomised controlled trial.
    Eur Respir J. 2021;57.
    >> Share

  164. SANTOS LD, Antunes KH, Muraro SP, de Souza GF, et al
    TNF-mediated alveolar macrophage necroptosis drives disease pathogenesis during respiratory syncytial virus infection.
    Eur Respir J. 2021;57.
    >> Share

  165. BENINCASA G, DeMeo DL, Glass K, Silverman EK, et al
    Epigenetics and pulmonary diseases in the horizon of precision medicine: a review.
    Eur Respir J. 2021;57.
    >> Share

    May 2021
  166. JENDZJOWSKY N, Laing A, Malig M, Matyas J, et al
    Long-term modulation of airway remodeling in severe asthma following bronchial thermoplasty.
    Eur Respir J. 2021 May 28. pii: 13993003.00622-2021.
    >> Share

  167. BENLALA I, Dournes G, Girodet PO, Benkert T, et al
    Evaluation of bronchial wall thickness in asthma using magnetic resonance imaging.
    Eur Respir J. 2021 May 28. pii: 13993003.00329-2021.
    >> Share

  168. SVERRILD A, Hansen S, Hvidtfeldt M, Clausson CM, et al
    The effect of tezepelumab on airway hyperresponsiveness to mannitol in asthma (UPSTREAM).
    Eur Respir J. 2021 May 28. pii: 13993003.01296-2021.
    >> Share

  169. HAKANSSON KEJ, Backer V, Suppli Ulrik C
    Socioeconomic biases in asthma control and specialist referral of possible severe asthma.
    Eur Respir J. 2021 May 13. pii: 13993003.00741-2021.
    >> Share

  170. JOHANSSON H, Wollmer P, Sundstrom J, Janson C, et al
    Bronchodilator response in FOT parameters in middle-aged adults from SCAPIS - normal values and relation to asthma and wheezing.
    Eur Respir J. 2021 May 6. pii: 13993003.00229-2021.
    >> Share

  171. BRUGIERE O, Verleden SE
    Putting the spotlight on macrophage-derived cathepsin in the pathophysiology of obliterative bronchiolitis.
    Eur Respir J. 2021;57.
    >> Share

  172. TAN WC, Bourbeau J, Nadeau G, Wang W, et al
    High eosinophil counts predict decline in FEV1: results from the CanCOLD study.
    Eur Respir J. 2021;57.
    >> Share

  173. MORRONE C, Smirnova NF, Jeridi A, Kneidinger N, et al
    Cathepsin B promotes collagen biosynthesis, which drives bronchiolitis obliterans syndrome.
    Eur Respir J. 2021;57.
    >> Share

    April 2021
  174. MCLEESE RH, Spinou A, Alfahl Z, Tsagris M, et al
    Psychometrics of HRQoL questionnaires in bronchiectasis: A systematic review and meta-analysis.
    Eur Respir J. 2021 Apr 22. pii: 13993003.00025-2021.
    >> Share

  175. GAILLARD EA, Kuehni CE, Turner S, Goutaki M, et al
    European Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5-16 years.
    Eur Respir J. 2021 Apr 19. pii: 13993003.04173-2020.
    >> Share

  176. DURACK T, Chapman DG, Rutting S, Thamrin C, et al
    Dynamic compliance and reactance in older non-smokers with asthma and fixed airflow obstruction.
    Eur Respir J. 2021 Apr 16. pii: 13993003.04400-2020.
    >> Share

  177. MARCON A, Locatelli F, Dharmage SC, Svanes C, et al
    The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories.
    Eur Respir J. 2021 Apr 16. pii: 13993003.04656-2020.
    >> Share

  178. ESTEVES P, Blanc L, Celle A, Dupin I, et al
    Crucial role of fatty acid oxidation in asthmatic bronchial smooth muscle remodelling.
    Eur Respir J. 2021 Apr 8. pii: 13993003.04252-2020.
    >> Share

  179. LUCCHETTI D, Santini G, Perelli L, Ricciardi-Tenore C, et al
    Detection and characterization of extracellular vesicles in exhaled breath condensate and sputum of COPD and severe asthma patients.
    Eur Respir J. 2021 Apr 1. pii: 13993003.03024-2020.
    >> Share

  180. TALAEI M, Hughes DA, Mahmoud O, Emmett PM, et al
    Dietary intake of vitamin A, lung function, and incident asthma in childhood.
    Eur Respir J. 2021 Apr 1. pii: 13993003.04407-2020.
    >> Share

  181. SPITZER C, Ewert R, Volzke H, Frenzel S, et al
    Childhood maltreatment and lung function: findings from the general population.
    Eur Respir J. 2021;57.
    >> Share

    March 2021
  182. HIGBEE DH, Nava GW, Kwong ASF, Dodd JW, et al
    The impact of asthma on mental health & wellbeing during COVID-19 lockdown.
    Eur Respir J. 2021 Mar 25. pii: 13993003.04497-2020.
    >> Share

  183. BRUSSELLE G, Nicolini G, Santoro L, Guastalla D, et al
    BDP/formoterol MART asthma exacerbation benefit increases with blood eosinophil level.
    Eur Respir J. 2021 Mar 18. pii: 13993003.040982020.
    >> Share

  184. PRICE OJ, Kucera KL, Price HM, Drezner JA, et al
    Asthma-related sudden death in athletes: A retrospective analysis of the U.S. NCCSIR database (1982-2018).
    Eur Respir J. 2021 Mar 7. pii: 13993003.00088-2021.
    >> Share

  185. WEE LE, Conceicao EP, Tan JY, Sim JXY, et al
    Reduction in asthma admissions during the COVID-19 pandemic: consequence of public health measures in Singapore.
    Eur Respir J. 2021 Mar 2. pii: 13993003.04493-2020.
    >> Share

  186. KNIHTILA HM, Kelly RS, Brustad N, Huang M, et al
    Maternal 17q21 genotype influences prenatal vitamin D effects on offspring asthma/recurrent wheeze.
    Eur Respir J. 2021 Mar 2. pii: 13993003.02012-2020.
    >> Share

  187. BOTTLE A, Quint J
    COPD: still an unpredictable journey.
    Eur Respir J. 2021;57.
    >> Share

  188. CHAPMAN DG, King GG
    To recline is to relax? Not when you have COPD!
    Eur Respir J. 2021;57.
    >> Share

  189. COLAK Y
    Cardiac disease from accelerated FEV1 decline and acute exacerbations: time to rethink comorbidities in COPD.
    Eur Respir J. 2021;57.
    >> Share

  190. CELLI B, Locantore N, Yates JC, Bakke P, et al
    Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort.
    Eur Respir J. 2021;57.
    >> Share

  191. WANG G, Hallberg J, Um Bergstrom P, Janson C, et al
    Assessment of chronic bronchitis and risk factors in young adults: results from BAMSE.
    Eur Respir J. 2021;57.
    >> Share

  192. WING K, Williamson E, Carpenter JR, Wise L, et al
    Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials.
    Eur Respir J. 2021;57.
    >> Share

  193. DI CAMPLI MP, Azouz A, Assabban A, Scaillet J, et al
    The mononuclear phagocyte system contributes to fibrosis in post-transplant obliterans bronchiolitis.
    Eur Respir J. 2021;57.
    >> Share

  194. TIEW PY, Dicker AJ, Keir HR, Poh ME, et al
    A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD.
    Eur Respir J. 2021;57.
    >> Share

  195. ELBEHAIRY AF, Faisal A, McIsaac H, Domnik NJ, et al
    Mechanisms of orthopnoea in patients with advanced COPD.
    Eur Respir J. 2021;57.
    >> Share

  196. WHITTAKER HR, Bloom C, Morgan A, Jarvis D, et al
    Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients.
    Eur Respir J. 2021;57.
    >> Share

    February 2021
  197. MASOLI M, Lanario JW, Hyland ME, Menzies-Gow A, et al
    The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference (MCID).
    Eur Respir J. 2021 Feb 25. pii: 13993003.00300-2021.
    >> Share

  198. REDDEL HK, Vestbo J, Agusti A, Anderson GP, et al
    Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort.
    Eur Respir J. 2021 Feb 25. pii: 13993003.03927-2020.
    >> Share

  199. CHANG AB, Fortescue R, Grimwood K, Alexopoulou E, et al
    Task Force report: European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis.
    Eur Respir J. 2021 Feb 11. pii: 13993003.02990-2020.
    >> Share

  200. BUSSE WW, Kraft M, Rabe KF, Deniz Y, et al
    Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation.
    Eur Respir J. 2021 Feb 4. pii: 13993003.03393-2020.
    >> Share

  201. WANG R, Alahmadi F, Niven R, Fowler SJ, et al
    Same-day repeatability of fractional exhaled nitric oxide in severe asthma.
    Eur Respir J. 2021 Feb 4. pii: 13993003.03391-2020.
    >> Share

  202. REDDEL HK
    Reply: About the recommendation of the GINA strategy report on asthma step 1.
    Eur Respir J. 2021;57.
    >> Share

  203. FERRETTI S, Gelsomino M, Miceli Sopo S
    About the recommendation of the GINA strategy report on asthma step 1.
    Eur Respir J. 2021;57.
    >> Share

  204. PENN RB
    Honing in on the effectors of oxidative stress in the asthmatic lung: oxidised phosphatidylcholines.
    Eur Respir J. 2021;57.
    >> Share

  205. BRUSASCO C, Corradi F, Di Domenico A, Raggi F, et al
    Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure.
    Eur Respir J. 2021;57.
    >> Share

  206. STOCKLEY RA
    COPD frequent exacerbators: time for the recycle bin?
    Eur Respir J. 2021;57.
    >> Share

  207. JANSON C, Lisspers K, Stallberg B, Johansson G, et al
    Osteoporosis and fracture risk associated with inhaled corticosteroid use among Swedish COPD patients: the ARCTIC study.
    Eur Respir J. 2021;57.
    >> Share

  208. CASS SP, Yang Y, Xiao J, McGrath JJC, et al
    Current smoking status is associated with reduced sputum immunoglobulin M and G expression in COPD.
    Eur Respir J. 2021;57.
    >> Share

  209. SADATSAFAVI M, McCormack J, Petkau J, Lynd LD, et al
    Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?
    Eur Respir J. 2021;57.
    >> Share

    January 2021
  210. ROGLIANI P, Ritondo BL, Calzetta L
    Triple therapy in uncontrolled asthma: a network meta-analysis of Phase III studies.
    Eur Respir J. 2021 Jan 28. pii: 13993003.04233-2020.
    >> Share

  211. GIAM YH, Shoemark A, Chalmers JD
    Neutrophil dysfunction in bronchiectasis: an emerging role for immunometabolism.
    Eur Respir J. 2021 Jan 28. pii: 13993003.03157-2020.
    >> Share

  212. TALAEI M, Sdona E, Calder PC, Jones LR, et al
    Intake of n-3 polyunsaturated fatty acids in childhood, FADS genotype, and incident asthma.
    Eur Respir J. 2021 Jan 28. pii: 13993003.03633-2020.
    >> Share

  213. BEAULIEU D, Attwe A, Breau M, Lipskaia L, et al
    Phospholipase A2-Receptor 1 Promotes Lung-Cell Senescence and Emphysema in Obstructive Lung Disease.
    Eur Respir J. 2021 Jan 28. pii: 13993003.00752-2020.
    >> Share

  214. RUFFLES T, Jones CJ, Palmer C, Turner S, et al
    Asthma prescribing according to Arg16Gly beta-2 genotype: a randomised trial in adolescents.
    Eur Respir J. 2021 Jan 21. pii: 13993003.04107-2020.
    >> Share

  215. MAGNAYE KM, Naughton KA, Huffman J, Hogarth DK, et al
    A-to-I editing of miR-200b-3p in airway cells is associated with moderate-to-severe asthma.
    Eur Respir J. 2021 Jan 14. pii: 13993003.03862-2020.
    >> Share

  216. MURRAY CS, Lucas SJ, Blakey J, Kaplan A, et al
    A real-life comparative effectiveness study into the addition of antibiotics to the management of asthma exacerbations in primary care.
    Eur Respir J. 2021 Jan 8. pii: 13993003.03599-2020.
    >> Share

  217. SIBILA O
    Reducing Pseudomonas sputum density in bronchiectasis.
    Eur Respir J. 2021;57.
    >> Share

  218. MOMEN NC, Liu X
    Maternal antibiotic use during pregnancy and asthma in children: population-based cohort study and sibling design.
    Eur Respir J. 2021;57.
    >> Share

  219. PLEASANTS RA, Tilley SL, Hickey AJ, Usmani OS, et al
    User-life of ICS/LABA inhaler devices should be considered when prescribed as relievers.
    Eur Respir J. 2021;57.
    >> Share

  220. SUNADOME H, Sato S, Matsumoto H, Murase K, et al
    Similar distribution of peripheral blood eosinophil counts in European and East Asian populations from investigations of large-scale general population studies: the Nagahama Study.
    Eur Respir J. 2021;57.
    >> Share

  221. LIN J, Huang N, Li J, Liu X, et al
    Cross-reactive antibodies against dust mite-derived enolase induce neutrophilic airway inflammation.
    Eur Respir J. 2021;57.
    >> Share

  222. GUIBERT N, Guilleminault L, Lepage B, Heluain V, et al
    Bronchial thermoplasty in patients with dynamic hyperinflation: results from the proof-of-concept HEAT trial.
    Eur Respir J. 2021;57.
    >> Share

    December 2020
  223. EGER K, Bel EH
    Asthma and COVID-19: do we finally have answers?
    Eur Respir J. 2020 Dec 30. pii: 13993003.04451-2020.
    >> Share

  224. MOORE A, Preece A, Sharma R, Heaney LG, et al
    A randomised controlled trial of the effect of a connected inhaler system on medication adherence in uncontrolled asthmatic patients.
    Eur Respir J. 2020 Dec 17. pii: 13993003.03103-2020.
    >> Share

  225. KRUG J, Kiefer A, Koelle J, Vuorinen T, et al
    TLR 7/8 regulates Type I and Type III Interferon Signalling in RV1b induced Allergic Asthma.
    Eur Respir J. 2020 Dec 10. pii: 13993003.01562-2020.
    >> Share

  226. LIU S, Jorgensen JT, Ljungman P, Pershagen G, et al
    Long-term exposure to low-level air pollution and incidence of asthma: the ELAPSE project.
    Eur Respir J. 2020 Dec 10. pii: 13993003.030992020.
    >> Share

  227. LONGO C, Blais L, Brownell M, Quail JM, et al
    Association between asthma control trajectories in preschoolers and disease remission.
    Eur Respir J. 2020 Dec 10. pii: 13993003.01897-2020.
    >> Share

  228. HERNANDEZ-PACHECO N, Vijverberg SJ, Herrera-Luis E, Li J, et al
    Genome-wide association study of asthma exacerbations despite inhaled corticosteroids use.
    Eur Respir J. 2020 Dec 10. pii: 13993003.03388-2020.
    >> Share

  229. CHO PSP, Fletcher HV, Patel IS, Turner RD, et al
    Cough Hypersensitivity and Suppression in Chronic Obstructive Pulmonary Disease.
    Eur Respir J. 2020 Dec 10. pii: 13993003.03569-2020.
    >> Share

  230. O'BYRNE PM, Pavord ID
    A golden age of asthma research.
    Eur Respir J. 2020;56.
    >> Share

  231. WALTERS EH, Shukla SD, Ward C
    Stability of eosinophilic inflammation in COPD bronchial biopsies.
    Eur Respir J. 2020;56.
    >> Share

  232. HIGHAM A, Singh D
    Stability of eosinophilic inflammation in COPD bronchial biopsies.
    Eur Respir J. 2020;56.
    >> Share

    November 2020
  233. CRICHTON ML, Dudgeon EK, Shoemark A, Chalmers JD, et al
    Validation of the Bronchiectasis Impact Measure (BIM) - a novel patient reported outcome measure.
    Eur Respir J. 2020 Nov 19. pii: 13993003.03156-2020.
    >> Share

  234. FARNE H, Singanayagam A
    Why asthma might surprisingly protect against poor outcomes in COVID-19.
    Eur Respir J. 2020 Nov 5. pii: 13993003.03045-2020.
    >> Share

  235. IZQUIERDO JL, Almonacid C, Gonzalez Y, Del Rio-Bermudez C, et al
    The Impact of COVID-19 on Patients with Asthma.
    Eur Respir J. 2020 Nov 5. pii: 13993003.03142-2020.
    >> Share

  236. MERKUS PJ, Pijnenburg MW
    Diagnosing asthma in children or adolescents/young adults? It is time for a change! How timing is everything, also in clinical practice.
    Eur Respir J. 2020;56.
    >> Share

  237. WHITMORE GA, Aaron SD
    Population-based case-finding to identify airflow obstruction in symptomatic adults at high risk for asthma and COPD.
    Eur Respir J. 2020;56.
    >> Share

  238. PERRET JL, Vicendese D, Dharmage SC
    Population-based case-finding to identify airflow obstruction in symptomatic adults at high risk for asthma and COPD.
    Eur Respir J. 2020;56.
    >> Share

  239. SAHANIC S, Boehm A, Pizzini A, Sonnweber T, et al
    Assessing self-medication for obstructive airway disease during COVID-19 using Google Trends.
    Eur Respir J. 2020;56.
    >> Share

    October 2020
  240. O'BYRNE PM, Reddel HK, Beasley R
    The Management of Mild Asthma.
    Eur Respir J. 2020 Oct 22. pii: 13993003.03051-2020.
    >> Share

  241. YAN Q, Forno E, Herrera-Luis E, Pino-Yanes M, et al
    A genome-wide association study of severe asthma exacerbations in Latino children and adolescents.
    Eur Respir J. 2020 Oct 22. pii: 13993003.02693-2020.
    >> Share

  242. HANON S, Brusselle G, Deschampheleire M, Louis R, et al
    COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry.
    Eur Respir J. 2020 Oct 22. pii: 13993003.02857-2020.
    >> Share

  243. PAPI A, Braithwaite I, Ebmeier S, Hancox B, et al
    Budesonide-formoterol reliever therapy in intermittent versus mild persistent asthma.
    Eur Respir J. 2020 Oct 15. pii: 13993003.03064-2020.
    >> Share

  244. ILMARINEN P, Pardo A, Tuomisto LE, Vahatalo I, et al
    Long-term prognosis of new adult-onset asthma in obese patients.
    Eur Respir J. 2020 Oct 8. pii: 13993003.01209-2020.
    >> Share

  245. HOLZ O, Waschki B, Watz H, Kirsten A, et al
    Breath volatile organic compounds and inflammatory markers in adult asthma patients - negative results from the ALLIANCE cohort.
    Eur Respir J. 2020 Oct 2. pii: 13993003.02127-2020.
    >> Share

  246. KERMANI NZ, Pavlidis S, Xie J, Sun K, et al
    Instability of sputum molecular phenotypes in U-BIOPRED severe asthma.
    Eur Respir J. 2020 Oct 2. pii: 13993003.01836-2020.
    >> Share

  247. O'NEILL C, Gibson PG, Heaney LG, Upham JW, et al
    The cost-effectiveness of azithromycin in reducing exacerbations in uncontrolled asthma.
    Eur Respir J. 2020 Oct 2. pii: 13993003.02436-2020.
    >> Share

  248. QUINN M, Turner AM
    Modernising case finding for alpha1-antitrypsin deficiency by DNA sequencing of COPD patients.
    Eur Respir J. 2020;56.
    >> Share

  249. GLANVILLE AR
    Pseudomonas and risk factor mitigation for chronic lung allograft dysfunction.
    Eur Respir J. 2020;56.
    >> Share

  250. CAVIEDES I, Soto R, Herth F
    The determination of ventilatory inefficiency at rest in COPD: the expected parameter.
    Eur Respir J. 2020;56.
    >> Share

    September 2020
  251. CHOI YJ, Park JY, Lee HS, Suh J, et al
    Effect of Asthma and Asthma Medication on the Prognosis of Patients with COVID-19.
    Eur Respir J. 2020 Sep 25. pii: 13993003.02226-2020.
    >> Share

  252. ASHER MI, Garcia-Marcos L, Pearce NE, Strachan DP, et al
    "Trends in worldwide asthma prevalence".
    Eur Respir J. 2020 Sep 24. pii: 13993003.02094-2020.
    >> Share

  253. DAI X, Bui D, Perret JL, Lowe A, et al
    Exposure to household air pollution over 10 years is related to asthma and lung function decline.
    Eur Respir J. 2020 Sep 17. pii: 13993003.00602-2020.
    >> Share

  254. THOMPSON CA, Eslick SR, Berthon BS, Wood LG, et al
    Asthma medication use in obese and healthy weight asthma: systematic review/meta-analysis.
    Eur Respir J. 2020 Sep 17. pii: 13993003.00612-2020.
    >> Share

  255. PASCOE CD, Jha A, Ryu MH, Ragheb M, et al
    Allergen inhalation generates pro-inflammatory oxidised phosphatidylcholine associated with airway dysfunction.
    Eur Respir J. 2020 Sep 3. pii: 13993003.00839-2020.
    >> Share

  256. CALVERLEY PMA, Farre R
    Oscillometry: old physiology with a bright future.
    Eur Respir J. 2020;56.
    >> Share

    August 2020
  257. CONNELL D, Shah A
    The contribution of Aspergillus fumigatus to COPD exacerbations: a "sensitive" topic.
    Eur Respir J. 2020;56.
    >> Share

  258. NANZER AM, D'Ancona G, Kelly PA, Jackson DJ, et al
    Diagnosing adrenal insufficiency using ACTH stimulation test.
    Eur Respir J. 2020;56.
    >> Share

  259. LIPWORTH B, Chan R, Kuo CR
    Diagnosing adrenal insufficiency using ACTH stimulation test.
    Eur Respir J. 2020;56.
    >> Share

    July 2020
  260. JOHNSON MJ, Ekstrom M, Currow DC
    Observational studies and "the eye of the beholder".
    Eur Respir J. 2020;56.
    >> Share

  261. KUGELMAN A
    High-flow nasal cannula therapy: can it be recommended as initial or rescue care for infants with moderate bronchiolitis in the paediatric ward?
    Eur Respir J. 2020;56.
    >> Share

  262. CHALMERS JD, Miravitlles M
    Withdrawal of inhaled corticosteroids in COPD.
    Eur Respir J. 2020;56.
    >> Share

  263. AGUSTI A
    Withdrawal of inhaled corticosteroids in COPD.
    Eur Respir J. 2020;56.
    >> Share

  264. TRINKMANN F, Watz H, Herth FJF
    Why do we still cling to spirometry for assessing small airway function?
    Eur Respir J. 2020;56.
    >> Share

  265. BOURDIN A, Gamez AS, Vachier I, Crestani B, et al
    LAM is another small airway disease: lessons from microCT.
    Eur Respir J. 2020;56.
    >> Share

  266. ARSHAD SH, Kurukulaaratchy R, Zhang H, Hodgekiss C, et al
    Assessing small airway function for early detection of lung function impairment.
    Eur Respir J. 2020;56.
    >> Share

    June 2020
  267. RUSSELL REK, Wang K
    Finding the true prevalence of obstructive lung disease: two steps forward and one step back.
    Eur Respir J. 2020;55.
    >> Share

  268. ROCHE N, Tonia T, Miravitlles M, Vaccaro V, et al
    Expanding the spectrum of European Respiratory Society official scientific documents: short documents complement clinical practice guidelines, statements and technical standards.
    Eur Respir J. 2020;55.
    >> Share

    May 2020
  269. DURAND P, Guiddir T, Kyheng C, Blanc F, et al
    A Randomised Trial of High-Flow Nasal Cannula in Infants with Moderate Bronchiolitis.
    Eur Respir J. 2020 May 7. pii: 13993003.01926-2019.
    >> Share

  270. STOLZ D, Miravitlles M
    The right treatment for the right patient with COPD: lessons from the IMPACT trial.
    Eur Respir J. 2020;55.
    >> Share

  271. VEDEL-KROGH S
    The search for the "healthy" blood eosinophil count.
    Eur Respir J. 2020;55.
    >> Share

  272. DE JONG CCM, Pedersen ESL, Mozun R, Goutaki M, et al
    A clinically significant bronchodilator response in children: how should it be measured?
    Eur Respir J. 2020;55.
    >> Share

  273. GUEZGUEZ F, Ben Saad H
    What constitutes a "clinically significant" bronchodilator response in children?
    Eur Respir J. 2020;55.
    >> Share

  274. HALPIN DMG, Dransfield MT, Han MK, Jones CE, et al
    The effect of exacerbation history on outcomes in the IMPACT trial.
    Eur Respir J. 2020;55.
    >> Share

  275. SCHEERENS C, Faes K, Pype P, Beernaert K, et al
    Earlier palliative home care is associated with patient-centred medical resource utilisation and lower costs in the last 30 days before death in COPD: a population-level decedent cohort study.
    Eur Respir J. 2020;55.
    >> Share

  276. MATHIOUDAKIS AG, Bikov A, Foden P, Lahousse L, et al
    Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD.
    Eur Respir J. 2020;55.
    >> Share

  277. HARTL S, Breyer MK, Burghuber OC, Ofenheimer A, et al
    Blood eosinophil count in the general population: typical values and potential confounders.
    Eur Respir J. 2020;55.
    >> Share

  278. JOGDAND P, Siddhuraj P, Mori M, Sanden C, et al
    Eosinophils, basophils and type 2 immune microenvironments in COPD-affected lung tissue.
    Eur Respir J. 2020;55.
    >> Share

  279. THULBORN SJ, Cane JL, Connolly C, Borg C, et al
    Evaluating the sensitivity and specificity of NEATstik technology compared to an activity-based immunoassay in sputum samples from participants with COPD.
    Eur Respir J. 2020;55.
    >> Share

  280. LEONG P, Ruane LE, Phyland D, Koh J, et al
    Inspiratory vocal cord closure in COPD.
    Eur Respir J. 2020;55.
    >> Share

    April 2020
  281. BEASLEY R, Braithwaite I, Semprini A, Kearns C, et al
    Achieving the balance between evidence and simplicity.
    Eur Respir J. 2020;55.
    >> Share

  282. LIPWORTH B, Kuo CR, Chan R
    Making simple things complicated using anti-inflammatory reliever therapy.
    Eur Respir J. 2020;55.
    >> Share

  283. DIVO MJ
    The adipose tissue and lung health: like many things in life, the extremes are not good.
    Eur Respir J. 2020;55.
    >> Share

    March 2020
  284. SUISSA S, Ernst P
    Avoiding immortal time bias in observational studies.
    Eur Respir J. 2020;55.
    >> Share

  285. RAYMAKERS AJN, Sadatsafavi M, Sin DD, FitzGerald JM, et al
    Avoiding immortal time bias in observational studies.
    Eur Respir J. 2020;55.
    >> Share

  286. COLAK Y, Nordestgaard BG, Vestbo J, Lange P, et al
    Outcomes consequent to "early" COPD for interventional studies.
    Eur Respir J. 2020;55.
    >> Share

  287. RENNARD SI
    Outcomes consequent to "early" COPD for interventional studies.
    Eur Respir J. 2020;55.
    >> Share

  288. POLVERINO F, Soriano JB
    Small airways and early origins of COPD: pathobiological and epidemiological considerations.
    Eur Respir J. 2020;55.
    >> Share

    November 2019
  289. BOUCLY A, Morelot-Panzini C, Garcia G, Weatherald J, et al
    Intensity and quality of exertional dyspnoea in patients with stable pulmonary hypertension.
    Eur Respir J. 2019 Nov 26. pii: 13993003.02108-2018.
    >> Share

  290. SUISSA S, Dell'Aniello S, Gonzalez AV, Ernst P, et al
    Inhaled corticosteroid use and the incidence of lung cancer in COPD.
    Eur Respir J. 2019 Nov 19. pii: 13993003.01720-2019.
    >> Share

    September 2019
  291. SPIRO SG, Shah PL, Rintoul RC, George J, et al
    Sequential screening for lung cancer in a high-risk group: randomised controlled trial.
    Eur Respir J. 2019 Sep 19. pii: 13993003.00581-2019.
    >> Share

  292. ROCHE N, Anzueto A, Bosnic Anticevich S, Kaplan A, et al
    The importance of real-life research in respiratory medicine: manifesto of the Respiratory Effectiveness Group: Endorsed by the International Primary Care Respiratory Group and the World Allergy Organization.
    Eur Respir J. 2019;54.
    >> Share

    August 2019
  293. KRISHNA MT, Subramanian A, Adderley NJ, Zemedikun D, et al
    Allergic Diseases and Long Term Risk of Autoimmune Disorders: longitudinal cohort study and cluster analysis.
    Eur Respir J. 2019 Aug 14. pii: 13993003.00476-2019.
    >> Share

    April 2019
  294. PICHL A, Sommer N, Bednorz M, Seimetz M, et al
    Riociguat for treatment of pulmonary hypertension in COPD - a translational study.
    Eur Respir J. 2019 Apr 7. pii: 13993003.02445-2018.
    >> Share

  295. RAYMAKERS AJN, Sadatsafavi M, Sin DD, FitzGerald JM, et al
    Inhaled corticosteroids and the risk of lung cancer in chronic obstructive pulmonary disease (COPD): a population-based cohort study.
    Eur Respir J. 2019 Apr 7. pii: 13993003.01257-2018.
    >> Share

    December 2018
  296. NATHAN SD, Barbera JA, Gaine SP, Harari S, et al
    Pulmonary hypertension in chronic lung disease and hypoxia.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01914-2018.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016